Calvert Investment Management’s Core Laboratories CLB Stock Holding History

Calvert Investment Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-13,142	Closed	-$1.58M	–	128
2016 Q4	$1.58M	Sell	13,142 -807	-6%	-$89.4K	0.06%	317
2016 Q3	$1.57M	Buy	13,949 +862	+7%	+$99.3K	0.06%	323
2016 Q2	$1.62M	Sell	13,087 -37,499	-74%	-$4.53M	0.07%	279
2016 Q1	$5.69M	Buy	50,586 +2,115	+4%	+$220K	0.25%	89
2015 Q4	$5.27M	Buy	48,471 +31,726	+189%	+$3.63M	0.24%	82
2015 Q3	$1.67M	Buy	16,745 +3,965	+31%	+$431K	0.08%	166
2015 Q2	$1.46M	Buy	12,780 +10,847	+561%	+$1.32M	0.06%	191
2015 Q1	$202K	Buy	1,933 +214	+12%	+$22.8K	0.01%	591
2014 Q4	$207K	Buy	+1,719	New	+$226K	0.01%	557

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Calvert Investment Management's CLB Position: Q1 2017 in Review

Calvert Investment Management sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 13,142 shares — an estimated $1.58M sold.

Calvert Investment Management first reported a position in CLB in Q4 2014 and held it in 9 quarters. The position peaked at $5.69M in Q1 2016. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

Calvert Investment Management reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
Calvert Investment Management sold 13,142 Core Laboratories shares in Q1 2017, an estimated $1.58M.
Calvert Investment Management first reported a position in Core Laboratories in Q4 2014 and held it in 9 quarters.
Calvert Investment Management's Core Laboratories position peaked at $5.69M in Q1 2016.
360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.